Heart Failure Due to Transthyretin Protein Amyloidosis

Systemic amyloidosis from transthyretin (ATTR) protein is increasingly recognized as an important cause of heart failure in older people. JAMA Deputy Editor Mary McGrae McDermott, MD, discusses the diagnosis and treatment of ATTR protein cardiomyopathy with Frederick L. Ruberg, MD, of the Boston University Chobanian & Avedisian School of Medicine. Related Content: Cardiac Amyloidosis Due to Transthyretin Protein

Episode metadata supplied by the publisher feed · Published Mar 5, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Heart Failure Due to Transthyretin Protein Amyloidosis

0:00 15:43

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Clinical Reviews?

This episode is 15 minutes long.

When was this JAMA Clinical Reviews episode published?

This episode was published on March 5, 2024.

Can I download this JAMA Clinical Reviews episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!